News
The largest clinical study of Bayer’s Xarelto® (rivaroxaban)
Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto® (rivaroxaban) to date, investigating...
Press Releases
Simcyp Signs Collaborative Research Agreement with US FDA to Extend Dog Simulator to Veterinary Medicines
Simcyp (now Certara) has entered into a Cooperative Research and Development Agreement (CRADA) with the US Food and Drug Administration (FDA) to further...
Press Releases
Clovis Oncology Announces Negative Outcome of CO-101 in Pivotal LEAP Pancreatic Cancer Study
Clovis Oncology, Inc. today announced the results from its LEAP (Low hENT1 and Adenocarcinoma of the Pancreas) study of CO-101 versus gemcitabine in...
News
A completely new way of delivering anti-cancer drugs
A completely new way of delivering anti-cancer drugs to tumours, using 'minicells' derived from bacteria, has been tested for the first time in...
Press Releases
S.M.A.R.T.® Vascular Stent Systems Receive FDA Approval for Use in SFA
Cordis Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved the S.M.A.R.T.® CONTROL® Vascular Stent Systems for use in...
News
Novartis future growth prospects secured by industry-leading pipeline
Novartis has provided an update on its leading Research and Development (R&D) pipeline and plans for turning these assets into commercial success to...
News
Scientists test 5,000 combinations of 100 existing cancer drugs to find more effective treatments
Scientists in the United States have tested all possible pairings of the 100 cancer drugs approved for use in patients in order to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read